Senators push pharma CEOs on drug prices

Inquiries from Congress continue to pile up with a growing focus on rising costs of insulin, as senators press pharmaceutical companies yet again to disclose drug pricing information.

Senate Health, Education, Labor and Pensions (HELP) Committee Ranking Member Sen.

Read the full 387 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE